Politics
Argan Shares Plunge 14% Amid Analyst Ratings and Insider Sales
Shares of Argan, Inc. (NYSE:AGX) fell sharply by 14% during midday trading on Friday, reaching a low of $276.28 before stabilizing at $306.52. This decline occurred against a backdrop of decreased trading volume, with approximately 269,861 shares exchanged, marking a 35% drop from the average daily volume of 412,463 shares. The stock had closed the previous day at $356.39.
Analysts have mixed views on Argan’s stock performance. Several research firms have recently updated their ratings. Weiss Ratings maintained a “buy (B)” rating on October 8. Meanwhile, JPMorgan Chase & Co. raised its price target from $315.00 to $370.00 while keeping a “neutral” rating. On the contrary, Zacks Research downgraded its rating from “strong-buy” to “hold” on November 12. In a contrasting development, Wall Street Zen upgraded the stock from “hold” to “buy” on September 5. Currently, three analysts rate the stock as a buy, while five maintain a hold rating. According to data from MarketBeat.com, the average rating for Argan stands at “hold” with a targeted average price of $321.00.
Recent Financial Performance and Dividend Increase
Argan reported its quarterly earnings on December 4, revealing earnings per share of $2.17, surpassing analysts’ expectations of $1.82 by $0.35. The company achieved a net margin of 12.73% and a return on equity of 32.61%. Revenue for the quarter reached $251.15 million, slightly below the consensus estimate of $251.50 million. This marks a 2.3% decline in revenue compared to the same quarter last year, when the company reported $2.00 in earnings per share.
In addition to its earnings report, Argan announced an increase in its quarterly dividend, which was paid on October 31. Shareholders of record on October 23 received a dividend of $0.50 per share, up from the previous $0.38. This reflects an annualized dividend of $2.00 and a yield of 0.7%, with a payout ratio of 24.04%.
Insider Trading Activity and Institutional Investments
Recent insider trading has also influenced market perceptions of Argan. Director William F. Leimkuhler sold 11,802 shares on October 1 at an average price of $274.73, totaling approximately $3.24 million. Following this sale, Leimkuhler retains 38,834 shares valued at around $10.67 million, representing a 23.31% decrease in his ownership.
Similarly, Director Peter W. Getsinger sold 6,493 shares on October 20 for about $1.91 million, which decreased his holdings by 39.62%. In total, insiders have sold 106,795 shares worth approximately $29.40 million over the past three months, with company insiders owning 6.69% of the stock.
Institutional investors have also been active in adjusting their positions in Argan. Vanguard Group Inc. increased its stake by 9.8% in the first quarter, now holding 926,168 shares valued at $121.49 million. First Trust Advisors LP significantly raised its holdings by 69.8% in the third quarter, acquiring an additional 230,073 shares for a total of $151.08 million. Other notable institutional investors include American Century Companies Inc. and Dimensional Fund Advisors LP, both of which have also increased their stakes.
As it stands, institutional and hedge fund investors collectively own 79.43% of Argan’s stock, reflecting substantial confidence in the company despite recent fluctuations in share price.
Argan, Inc. specializes in engineering, procurement, construction, commissioning, maintenance, project development, and technical consulting services, primarily serving the power generation sector. The company operates through its Power Services, Industrial Services, and Telecom Services segments, providing solutions for alternative energy projects such as biomass plants, wind farms, and solar fields.
-
Science2 months agoInventor Achieves Breakthrough with 2 Billion FPS Laser Video
-
Health2 months agoCommunity Unites for 7th Annual Into the Light Walk for Mental Health
-
Top Stories2 months agoCharlie Sheen’s New Romance: ‘Glowing’ with Younger Partner
-
Entertainment2 months agoDua Lipa Aces GCSE Spanish, Sparks Super Bowl Buzz with Fans
-
Health2 months agoCurium Group, PeptiDream, and PDRadiopharma Launch Key Cancer Trial
-
Entertainment2 months agoMother Fights to Reunite with Children After Kidnapping in New Drama
-
Top Stories2 months agoFormer Mozilla CMO Launches AI-Driven Cannabis Cocktail Brand Fast
-
World2 months agoIsrael Reopens Rafah Crossing After Hostage Remains Returned
-
Business2 months agoTyler Technologies Set to Reveal Q3 Earnings on October 22
-
Health2 months agoNorth Carolina’s Biotech Boom: Billions in New Investments
-
World2 months agoR&B Icon D’Angelo Dies at 51, Leaving Lasting Legacy
-
Entertainment2 months agoRed Sox’s Bregman to Become Free Agent; Tigers Commit to Skubal
